Teladoc Health Inc (TDOC)
11.94
-0.30
(-2.41%)
USD |
NYSE |
May 10, 16:00
11.91
-0.04
(-0.29%)
After-Hours: 20:00
Teladoc Health Cash from Investing (TTM): -146.24M for March 31, 2024
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
March 31, 2024 | -146.24M |
December 31, 2023 | -156.35M |
September 30, 2023 | -173.73M |
June 30, 2023 | -177.53M |
March 31, 2023 | -185.80M |
December 31, 2022 | -167.74M |
September 30, 2022 | -133.93M |
June 30, 2022 | -127.19M |
March 31, 2022 | -84.52M |
December 31, 2021 | -72.98M |
September 30, 2021 | -466.83M |
June 30, 2021 | -587.58M |
March 31, 2021 | -595.08M |
December 31, 2020 | -590.98M |
September 30, 2020 | -167.50M |
June 30, 2020 | 1.151M |
March 31, 2020 | 5.749M |
December 31, 2019 | 25.01M |
September 30, 2019 | -26.88M |
Date | Value |
---|---|
June 30, 2019 | -39.62M |
March 31, 2019 | -274.13M |
December 31, 2018 | -257.50M |
September 30, 2018 | -206.81M |
June 30, 2018 | -647.13M |
March 31, 2018 | -403.42M |
December 31, 2017 | -448.38M |
September 30, 2017 | -443.01M |
June 30, 2017 | -14.84M |
March 31, 2017 | -6.917M |
December 31, 2016 | 26.15M |
September 30, 2016 | 26.70M |
June 30, 2016 | -66.22M |
March 31, 2016 | -92.06M |
December 31, 2015 | -108.20M |
September 30, 2015 | -122.97M |
June 30, 2015 | -18.62M |
March 31, 2015 | -19.24M |
December 31, 2014 | -15.58M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-595.08M
Minimum
Mar 2021
25.01M
Maximum
Dec 2019
-193.43M
Average
-151.29M
Median
Cash from Investing (TTM) Benchmarks
Omnicell Inc | -53.72M |
Phreesia Inc | -39.67M |
10x Genomics Inc | 24.17M |
Biote Corp | -2.713M |
American Shared Hospital Services | -6.273M |